Photobiomodulation Therapy and Cell Therapy Improved Parkinson’s Diseases by Neuro-regeneration and Tremor Inhibition

Parkinson’s disease (PD) is a neurodegenerative disorder affecting the central nervous system, characterized by cell reduction in the substantia nigra and α-synuclein accumulation. Besides drug treatment, therapies like surgery, cell therapy, and laser therapy can be explored. This review evaluates the potential of cell therapy and laser therapy in PD for improving motor function, cell differentiation, and dopaminergic cell proliferation.

• 1
  Cell therapy, particularly using mesenchymal stem cells (MSCs), shows promise due to their self-renewal, differentiation, and immunomodulatory properties.
• 2
  Photobiomodulation (PBM) therapy can reduce oxidative stress, increase growth factors, promote cell proliferation, and reduce inflammation.
• 3
  Combining cell therapy and photobiomodulation may enhance the treatment of PD symptoms.